Workflow
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
INSMInsmed(INSM) Zacks Investment Research·2024-05-10 16:15

Insmed (INSM) reported a loss of 1.06pershareinthefirstquarterof2024,narrowerthantheZacksConsensusEstimateofalossof1.06 per share in the first quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 1.22. In the year-ago quarter, the company posted a loss of 1.17.Insmedgeneratedtotalrevenuesof1.17.Insmed generated total revenues of 75.5 million during the quarter, which were up 16% year over year. The reported sales missed the Zacks Consensus Estimate of $78.9 million.Quarter in DetailIn the reported quarter, total revenues were generated entirely from product revenues of Insmed’s only marketed drug, ...